We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
According to data of EvaluatePharma, the top 2 on the following list are Kite Pharma’s CAR-T therapy and Incyte’s IDO inhibitor, and DBV’s peanut allergy vaccine and Karyopharm’s cancer treatment selinexor also rank in the top 15.